Nihat Farisogullari
Overview
Explore the profile of Nihat Farisogullari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Basaran E, Tanacan A, Farisogullari N, Agaoglu Z, Sahin R, Akgun Aktas B, et al.
Women Health
. 2025 Jan;
65(2):140-153.
PMID: 39745673
In this study, we investigated the factors that influence families' decision-making processes about whether to carry a pregnancy to term or to terminate it in cases of fetal anomalies. A...
2.
Basaran E, Tanacan A, Farisogullari N, Agaoglu Z, Ozkavak O, Kara O, et al.
J Perinat Med
. 2024 Oct;
53(1):39-47.
PMID: 39392658
Objectives: To examine the relationship between the lower uterine segment (LUS) thickness and the onset of labor in dichorionic twin pregnancies experiencing threatened preterm labor. Methods: This prospective cohort study...
3.
Sakcak B, Tanacan A, Denizli R, Farisogullari N, Ozkavak O, Aktas S, et al.
J Clin Ultrasound
. 2024 Sep;
53(1):5-9.
PMID: 39246291
Purpose: This study aims to investigate the fetal Evans Index and establish a nomogram for fetuses without any additional fetal anomalies detected during the prenatal period. Methods: We conducted our...
4.
Farisogullari N, Tanacan A, Sakcak B, Denizli R, Ozdemir E, Elmas B, et al.
Int J Gynaecol Obstet
. 2024 Jul;
167(3):1201-1206.
PMID: 39016277
Objective: To compare the levels of oxidative stress markers in the umbilical cord blood between pregnant women diagnosed with iron deficiency anemia (IDA) and low-risk controls. Methods: The sample consisted...
5.
Tanacan A, Sakcak B, Denizli R, Agaoglu Z, Farisogullari N, Kara O, et al.
Arch Gynecol Obstet
. 2024 Mar;
310(1):377-385.
PMID: 38453730
Purpose: To evaluate the utility of a novel ultrasound index "combined utero-cervical index (CUCI)" in the prediction of preterm delivery. Methods: The present prospective cohort study was conducted in Ankara...
6.
Denizli R, Tanacan A, Bastemur A, Sakcak B, Farisogullari N, Kara O, et al.
J Obstet Gynaecol Res
. 2024 Feb;
50(4):611-617.
PMID: 38325805
Aim: We aim to compare the maternal serum thiol and ischemia-modified albumin (IMA) levels between pregnant women with placenta previa and those with uncomplicated pregnancies and to determine whether changes...
7.
Farisogullari N, Tanacan A, Sakcak B, Denizli R, Bastemur A, Basaran E, et al.
Cytokine
. 2024 Jan;
176:156513.
PMID: 38262117
Objective: Our study aimed to differentiate patients with placenta accreta spectrum (PAS) from those with placenta previa (PP) using maternal serum levels of vascular endothelial growth factor (VEGF), tumor necrosis...
8.
Farisogullari N, Tanacan A, Sakcak B, Denizli R, Ozkavak O, Turgut E, et al.
J Interferon Cytokine Res
. 2023 Dec;
43(12):557-564.
PMID: 38126935
We aimed to examine the relationship between serum midkine levels and placental invasion in pregnant women with placenta previa. The study group consisted of 43 pregnant women diagnosed with placenta...
9.
Farisogullari N, Denizli R, Sakcak B, Tanacan A, Kara O, Sahin D
Rev Bras Ginecol Obstet
. 2023 Sep;
45(8):e439-e446.
PMID: 37683655
Objective: To evaluate the fetal and maternal effects of the severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection in women with hypertensive disorders of pregnancy. Methods: Patients with hypertensive disorders...
10.
Farisogullari N, Tanacan A, Sakcak B, Denizli R, Basaran E, Kara O, et al.
Int J Gynaecol Obstet
. 2023 Sep;
164(3):979-984.
PMID: 37680091
Objective: This study aimed to investigate maternal serum vascular endothelial growth factor (VEGF) C and D levels in patients with intrahepatic cholestasis of pregnancy (ICP). Methods: A total of 83...